1. Brozek JL, Bousquet J, Baena-Cagnani CE, et al.

    Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision.

    J Allergy Clin Immunol. 2010;126(3):466-76

  2. Seidaman MD, Gurgel RK, Lin SY, et al.

    Clinical practice guideline: Allergic rhinitis.

    Otolaryngol Head Neck Surg. 2015;152(1 Suppl):S1-43.

  3. Wallace DV, Dykewicz MS, Oppenheimer J, et al.

    Pharmacologic Treatment of Seasonal Allergic Rhinitis: Synopsis of Guidance From the 2017 Joint Task Force on Practice Parameters.

    Ann Intern Med. 2017;167(12):876–881.

  4. Wise SK, Lin SY, Toskala E, et al.

    International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis.

    Int Forum Allergy Rhinol. 2018;8(2):108–352.

  5. Weinstein S, Qaqundah P, Georges G, et al.

    Efficacy and safety of triamcinolone acetonide aqueous nasal spray in children aged 2 to 5 years with perennial allergic rhinitis: a randomized, double-blind, placebo-controlled study with an open-label extension. Ann Allergy Asthma Immunol.


  6. Schenkel EJ, Gross G, Jacobson K, et al.

    Triamcinolone Acetonide Aqueous Nasal Inhaler for the Treatment of Spring Grass Seasonal Allergic Rhinitis in Children.

    Pediatr Asthma Allergy Immunol. 1997; 11(2):129–136.

  7. Skoner DP, Berger WE, Gawchik SM, et al.

    Intranasal triamcinolone and growth velocity.

    Pediatrics. 2015;135(2):e348-356.